Search results for "Cutaneous"

showing 10 items of 1022 documents

Intralipotherapy, the State of the Art.

2016

Background: Reconstruction intralipotherapy is a term commonly used in the field of aesthetic medicine, above all in Europe, which defines a specific injection technique developed for the treatment of localized fat with substances that provoke the lysis of adipocytes by means of an injection directly into the adipose tissue with a long needle. The aim of this study is to define the technique in detail and everything that is associated with it, on the basis of years of multicenter experience by doctors who perform it. Materials and Methods: From January 2010 to December 2014, 3,080 European physicians were trained in intralipotherapy technique, and approximately 152,500 patients were treated…

Protocol (science)medicine.medical_specialtybusiness.industryLocalized fatBackground reconstructionIntralipotherapy Reconstruction protocol030230 surgerySubcutaneous fatSurgeryPostoperative managementSettore MED/18 - Chirurgia Generale030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineMedicineSurgeryAesthetic medicineOriginal ArticlebusinessAdverse effectPlastic and reconstructive surgery. Global open
researchProduct

Vaccination with TAT-Antigen Fusion Protein Induces Protective, CD8+ T Cell-Mediated Immunity Against Leishmania Major

2010

In murine leishmaniasis, healing is mediated by IFN-γ-producing CD4 + and CD8 + T cells. Thus, an efficacious vaccine should induce Th1 and Tc1 cells. Dendritic cells (DCs) pulsed with exogenous proteins primarily induce strong CD4-dependent immunity; induction of CD8 responses has proven to be difficult. We evaluated the immunogenicity of fusion proteins comprising the protein transduction domain of HIV-1 TAT and the Leishmania antigen LACK ( Leishmania homolog of receptors for activated C kinase), as TAT-fusion proteins facilitate major histocompatibility complex class I-dependent antigen presentation. In vitro , TAT–LACK-pulsed DCs induced stronger proliferation of Leishmania -specific C…

Protozoan VaccinesAntigen presentationProtozoan ProteinsLeishmaniasis CutaneousAntigens ProtozoanDermatologyCD8-Positive T-LymphocytesBiologyMajor histocompatibility complexBiochemistryArticleMiceAntigenAnimalsCytotoxic T cellLeishmania majorMolecular BiologyLeishmania majorImmunogenicityDendritic CellsCell BiologyTh1 Cellsbiology.organism_classificationInterleukin-12Fusion proteinMice Mutant StrainsCell biologyMice Inbred C57BLImmunologybiology.proteintat Gene Products Human Immunodeficiency VirusViral Fusion ProteinsCD8Journal of Investigative Dermatology
researchProduct

Cutaneous Toxicity Induced by Hibiscus Tea in a Patient Treated with Erlotinib

2017

Pulmonary and Respiratory MedicineHerb-drug interactionsbiologybusiness.industryCutaneous toxicityPharmacologyHibiscusbiology.organism_classification030226 pharmacology & pharmacy03 medical and health sciences0302 clinical medicineOncology030220 oncology & carcinogenesisMedicineErlotinibbusinessSkin pathologymedicine.drugJournal of Thoracic Oncology
researchProduct

Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma.

2019

Systemic/oral corticosteroids (OCS) have been used for decades in the management of acute asthma exacerbations and chronically in patients with uncontrolled severe asthma. However, while OCS are effective at treating acute exacerbations, there is only empirical evidence regarding the efficacy of OCS at reducing the rate of exacerbations. Evidence, although scarce, is suggestive of high exacerbation rates in severe asthma patients even when receiving maintenance treatment with OCS. In addition, use of OCS is associated with undesirable effects. Despite all this, physicians have continued to use OCS for managing severe asthma and acute exacerbation due to the lack of availability of effective…

Pulmonary and Respiratory MedicineMaleAllergymedicine.medical_specialtyExacerbationInjections SubcutaneousAdministration OralOmalizumabOmalizumabAntibodies Monoclonal HumanizedSeverity of Illness Indexchemistry.chemical_compoundReslizumabAdrenal Cortex HormonesInternal medicinemedicineHumansAnti-Asthmatic AgentsAsthmaBiological Productsbusiness.industryInterleukin-4 Receptor alpha SubunitImmunoglobulin Emedicine.diseaseBenralizumabReceptors Interleukin-5DupilumabAsthmachemistryAdministration IntravenousFemaleInterleukin-5businessMepolizumabmedicine.drug
researchProduct

Pulmonary microvascular architecture in hereditary haemorrhagic telangiectasia

2017

A 24-year-old Caucasian man was admitted with a known hereditary haemorrhagic telangiectasia (HHT) and heterozygous mutation of factor V Leiden following episodes of cerebral infarctions in occipital lobes, cerebellum and brainstem. In his case history, the patient underwent several interventional embolisation of arteriovenous (AV) malformations in the middle and lower lobes (figure 1). However, those were not completely successful as the malformations were diffuse. We performed video-assisted thoracoscopic surgery with a resection of the middle lobe and a wedge resection of segment 10. Figure 1 CT scans depict the pulmonary arteriovenous malformations after re-embolisation in the middle lo…

Pulmonary and Respiratory MedicineMalecongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyMucocutaneous zoneMedizinArticleResection03 medical and health sciencesYoung Adult0302 clinical medicineMicroscopy Electron Transmissionhemic and lymphatic diseasesotorhinolaryngologic diseasesmedicineFactor V LeidenHumans030223 otorhinolaryngologyLungHeterozygous mutationHereditary haemorrhagic telangiectasiabusiness.industryMiddle LobeMicrovascular architecturemedicine.diseaseSurgery030228 respiratory systemMicrovesselsTelangiectasia Hereditary HemorrhagicRadiologybusinessTomography X-Ray ComputedWedge resection (lung)
researchProduct

Tracheostomy in patients with long-term mechanical ventilation: a survey.

2010

Summary Background Tracheostomy is increasingly performed in intensive care units (ICU), with many patients transferred to respiratory ICU (RICU). Indications/timing for closing tracheostomy are discussed. Aim and Method We report results of a one-year survey evaluating: 1) clinical characteristics, types of tracheostomy, complications in patients admitted to Italian RICU in 2006; 2) clinical criteria and systems for performing decannulation, and outcome of patients undergoing tracheostomy (number decannulated; number non-decannulated/non-ventilated; number non-decannulated/ventilated; dead/lost patients). Results 22/32 RICUs replied. There were 846 admissions of 719 patients (Mean age 64,3…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyPercutaneousSettore MED/09 - Medicina InternaExacerbationCritical Caremedicine.medical_treatmentRespiratory failureSettore MED/10 - Malattie Dell'Apparato Respiratoriolaw.inventionTracheostomylawIntensive caremedicineHumansIn patientIntensive care unitMechanical ventilationbusiness.industryLong-term mechanical ventilationMiddle Agedmedicine.diseasePrognosisIntensive care unitRespiration ArtificialSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheSurgeryObstructive sleep apneaTreatment OutcomeRespiratory failureItalyHealth Care SurveysTracheostomy Intensive care unit Long-term mechanical ventilation Respiratory failureFemalebusinessRespiratory InsufficiencyVentilator Weaning
researchProduct

Feasibility of transcatheter aortic valve implantation in patients with coronary heights ≤7 mm: insights from the transcatheter aortic valve implanta…

2018

OBJECTIVES Transcatheter aortic valve implantation (TAVI) in patients with low coronary heights is generally denied but is not impossible. Information about these high-risk procedures is sparse. METHODS Since May 2008, data of more than 3000 patients who had TAVI were prospectively collected in the institutional TAVI Karlsruhe registry. Characteristics, peri- and postoperative outcome of patients with low coronary heights of ≤7 mm were analysed according to the Valve Academic Research Consortium-2. RESULTS Eighty-six patients with an average coronary height of 6.4 ± 1.1 mm (mean age 81.0 ± 5.3 years, logistic EuroSCORE I 19.6 ± 13.3%) were treated. TAVI was performed in 72 transfemoral (83.…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtymedicine.medical_treatment030204 cardiovascular system & hematologyCoronary AngiographyTranscatheter Aortic Valve Replacement03 medical and health sciences0302 clinical medicinePostoperative ComplicationsValve replacementGermanyMedicineHumans030212 general & internal medicineProspective StudiesRegistriesProspective cohort studyAortic dissectionAged 80 and overBioprosthesisbusiness.industryMortality rateIncidenceHazard ratioExtracorporeal circulationPercutaneous coronary interventionGeneral MedicineAortic Valve Stenosismedicine.diseaseCoronary VesselsSurgerySurvival RateTreatment OutcomeCoronary OcclusionCoronary occlusionAortic ValveFluoroscopyFeasibility StudiesSurgeryFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
researchProduct

Shedding some light on tricuspid intervention

2021

Background More than 1.6 million Americans have at least moderate to severe valvular tricuspid regurgitation, yet fewer than 8000 tricuspid valve operations are performed annually in the USA. The undertreatment for isolated tricuspid regurgitation might be related to the fact that in the past years no clear guidelines on 'how' and 'when' to treat tricuspid regurgitation were issued. Aims Sarris-Michopoulos and colleagues carried out a meta-analysis with the aim to investigate the role of tricuspid valve repair versus tricuspid valve replacement in patients with isolated tricuspid valve regurgitation. Material and methods Outcomes of patients with first-time surgery for isolated tricuspid va…

Pulmonary and Respiratory MedicineModerate to severecongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyPercutaneousContext (language use)Regurgitation (circulation)Intervention (counseling)Internal medicineHumansMedicinecardiovascular diseasesRetrospective StudiesHeart Valve Prosthesis ImplantationTricuspid valvebusiness.industryTricuspid Valve InsufficiencySurgeryTreatment Outcomemedicine.anatomical_structureVentricleCohortcardiovascular systemCardiologySurgeryTricuspid ValveTricuspid Valve RegurgitationCardiology and Cardiovascular Medicinebusiness
researchProduct

Spontaneous pneumomediastinum and subcutaneous emphysema as a complication of asthma in children: case report and literature review

2016

Background:Spontaneous pneumomediastinum (SPM) is an uncommon disorder. It is rarely reported in paediatric patients and may be accompanied by subcutaneous emphysema. It is usually benign and self-limiting, with only supportive therapy being needed, but severe cases may require invasive measures. Asthma exacerbations have classically been described as a cause of SPM. However, detailed descriptions in asthmatic children are scarce. We aimed at improving the current understanding of the features of SPM and subcutaneous emphysema, and outcomes, by means of a case report and a systematic review.Methods:For the systematic review a literature search was performed in PubMed to identify reported ca…

Pulmonary and Respiratory MedicinePediatricsmedicine.medical_specialtyspontaneous pneumomediastinumUncommon disorder03 medical and health sciences0302 clinical medicinechildrensystematic review030225 pediatricsMedicinecase reportHumansPharmacology (medical)Sublingual immunotherapy030212 general & internal medicineAnti-Asthmatic AgentsChildMediastinal EmphysemaAsthmaOriginal Researchlcsh:RC705-779business.industryAsthma symptomssubcutaneous emphysemalcsh:Diseases of the respiratory systemasthmamedicine.diseaseDyspneaTreatment OutcomeCoughSupportive psychotherapyAnesthesiaSpontaneous pneumomediastinumFemalemedicine.symptombusinessComplicationSubcutaneous emphysemaTherapeutic Advances in Respiratory Disease
researchProduct

Branch ligatures and blood aspiration for post-traumatic superficial temporal artery pseudoaneurysm: surgical technique

2014

The aim of this study is to report a new minimally invasive technique of superficial temporal artery (STA) pseudoaneurysm treatment. Several surgical options have been employed to treat STA pseudoaneurysms. To address this rare condition, the employed techniques are ligation and excision of the aneurysm, endovascular coil embolization or percutaneous ultrasound-guided thrombin injection. Between techniques no significant differences are reported in terms of outcomes. The decision to adopt a technique depends on STA pseudoaneurysm morphology and surgeon preference. In the present report, STA pseudoaneurysm afferent and efferent branches were identified by ultrasound in a 92-year-old female. …

Pulmonary and Respiratory Medicinemedicine.medical_specialtyPercutaneousDecompression610 Medicine & healthSettore MED/22 - Chirurgia Vascolaredigestive system2705 Cardiology and Cardiovascular MedicinePseudoaneurysmAneurysmmedicine.arterymedicineCraniocerebral TraumaHumansMinimally Invasive Surgical Procedurescardiovascular diseasesLigationAged 80 and over10042 Clinic for Diagnostic and Interventional Radiologybusiness.industryTemporal Artery Pseudoaneurysm Post-traumaticGeneral Medicinemedicine.diseaseSuperficial temporal artery10020 Clinic for Cardiac Surgery2746 SurgerySurgeryCardiac surgeryTemporal Arteriesmedicine.anatomical_structure2740 Pulmonary and Respiratory MedicineCardiothoracic surgerycardiovascular systemSurgeryFemaleRadiologyCardiology and Cardiovascular MedicinebusinessAneurysm FalseArtery
researchProduct